Call for Abstract

34th World Congress on Vaccines and Immunization, will be organized around the theme “Progress and novel strategies in Vaccine Development”

Vaccines Congress 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Vaccines Congress 2019

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Vaccination has long been an effective way to decrease disease burden in pets and farm animals, and is one of the key tool in maintaining animal health and welfare. Vaccines continue to play an increasingly vital role in preventative health and disease control programmes in animals. Innovative research and the development of safe, effective and quality vaccines means that our pets and farm animals continue to benefit from vital medicines that prevent or alleviate clinical signs of disease.


  • Track 1-1Animal immunizations
  • Track 1-2Innovations in animal vaccines
  • Track 1-3Livestock animal vaccines and vaccinations
  • Track 1-4Pet vaccines and vaccinations
  • Track 1-5Veterinary vaccines for animals
  • Track 1-6Tetanus, diphtheria, acellular pertussis vaccine during pregnancy
  • Track 1-7Vaccine Administration, Storage & Handling

Bacterial vaccines contain executed or constricted microbes that actuate the resistant framework. Antibodies are worked against that specific microorganisms and avoids bacterial disease later. A case of a bacterial immunization is the Tuberculosis vaccine.


  • Track 2-1Diphtheria and tetanus toxoids usage in pediatrics
  • Track 2-2Inactivated bacterial vaccines
  • Track 2-3Innovative toxoid vaccine development
  • Track 2-4Live attenuated bacterial vaccinations
  • Track 2-5Maternal immunization

Some propelled stage clinical trials of HIV immunization are continuous. Even though the production of a compelling HIV-1 antibody remains a tremendous test, the proceeding with advance in these zones gives motivation to be idealistic about our definitive capacity to control the spread of AIDS. Development of a HIV/AIDS immunization has been easing back on the grounds that established ways to deal with antibody improvement have not yielded an antibody.


  • Track 3-1Age acceleration effects due to HIV infection
  • Track 3-2Attenuated Virus Vaccines in HIV Infection
  • Track 3-3HIV stems vaccination
  • Track 3-4HIV Vaccine development from Animal Models
  • Track 3-5Microbicides for sexually Transmitted Diseases
  • Track 3-6Recombinant vector vaccine

Vaccination is the best technique for forestalling irresistible diseases; far reaching invulnerability because of inoculation is to a great extent in charge of the overall annihilation of smallpox and the disposal of illnesses, for example, polio, measles, and lockjaw from a great part of the world. Maternal inoculation is a viable technique to forestall as well as limit the seriousness of irresistible illnesses in pregnant ladies and their newborn children.


  • Track 4-1Chickenpox vaccine
  • Track 4-2Diphtheria vaccines
  • Track 4-3Haemophilus influenza type b vaccines
  • Track 4-4Hepatitis A vaccines
  • Track 4-5Hepatitis B vaccines
  • Track 4-6Influenza vaccines
  • Track 4-7MMR vaccines
  • Track 4-8Pneumococcal Vaccine
  • Track 4-9Polio vaccines

An antibody is a natural readiness that gives dynamic obtained invulnerability to a specific ailment. An antibody regularly contains an operator that takes after a malady causing microorganism and is frequently produced using debilitated or executed types of the organism, its poisons or one of its surface proteins. The operator invigorates the body's insusceptible framework to perceive the specialist as a danger, annihilate it, and perceive and devastate any of these microorganisms that it later experiences. Antibodies can be prophylactic, or helpful. The organization of immunizations is called inoculation. The viability of inoculation has been broadly considered and confirmed.


  • Track 5-1Cost effective production
  • Track 5-2Vaccines Awareness
  • Track 5-3Vaccines Investments and partnerships
  • Track 5-4Vaccines Marketing

Protein based subunit antibodies exhibit an antigen to the safe framework without viral particles, utilizing a particular, confined protein of the pathogen.Acellular pertussis (AP) antibodies contain inactivated pertussis poison (protein) and may contain at least one other bacterial parts.

Hepatitis B immunizations are made out of the hepatitis B infection surface antigen (HbsAg), a protein created by hepatitis B infection. Prior immunization items were created utilizing purged plasma of tainted people. This creation technique has been supplanted by recombinant innovation that can deliver HbsAg without requiring human plasma expanding the security of the immunization by barring the hazard from potential tainting of human plasma.


  • Track 6-1Contraindications - Vaccines, vaccination
  • Track 6-2New approaches to combat bacterial pathogens
  • Track 6-3Public health concerns in vaccination
  • Track 6-4Vaccine resistance and need of Next-Gen Conjugate Vaccines
  • Track 6-5Vaccines formulation and technologies used in conjugated vaccines

Plant-based immunization advancements include the coordination of the coveted qualities encoding the antigen protein for particular illness into the genome of plant tissues by different strategies. Agrobacterium-interceded quality exchange and change by means of hereditarily altered plant infection are the normal techniques that have been utilized to create viable antibodies. Indeed, even with every one of the impediments, nonstop endeavors are as yet progressing so as to create effective immunization for some human and creature’s related sicknesses attributable to its awesome possibilities.


  • Track 7-1Biotherapeutics
  • Track 7-2Purified subunit vaccines
  • Track 7-3Recombinant subunit vaccine
  • Track 7-4Vaccines under research

Antibody viability alludes to the capacity of immunizations to achieve the expected advantageous impacts on inoculated people in a characterized populace under perfect states of utilization. Antibody related hazard is the likelihood of an unfriendly or undesirable result happening and the seriousness of the subsequent damage to the strength of inoculated people in a characterized populace following vaccination with an immunization under perfect states of utilization.


  • Track 8-1Decreases in disease risks and increased attention on vaccine risks.
  • Track 8-2Vaccine Safety Monitoring and Vaccine Pharmacovigilance
  • Track 8-3Vaccine safety communication
  • Track 8-4Public confidence in vaccine safety is critical
  • Track 8-5Post marketing surveillance of Vaccines
  • Track 8-6Patient and Public acceptance and perceptions
  • Track 8-7Higher standard of safety is expected of vaccines
  • Track 8-8Factors Influencing Vaccine efficacy
  • Track 8-9Factors Influencing Vaccine efficacy
  • Track 8-10Vaccines generally healthy (vs. ill for drugs)

As we get more seasoned, our invulnerable framework has a tendency to debilitate after some time, putting us at higher hazard for specific infections. This is the reason, notwithstanding regular influenza immunization and Td or Tdap antibody, the grown-ups 60 years or more seasoned should take Pneumococcal antibodies, which secure against pneumococcal illness, incorporating diseases in the lungs and circulation system and Zoster immunization, which ensures against shingles.


  • Track 9-1Contraindications and precautions during vaccination in geriatrics
  • Track 9-2Flu shots for seniors
  • Track 9-3Herpes zoster vaccines
  • Track 9-4Immunization and its side effects in geriatrics
  • Track 9-5Immunization schedule for elderly people
  • Track 9-6Pneumococcal polysaccharide vaccines
  • Track 9-7Risk factors in geriatric immunization
  • Track 9-8Vaccine dosing and administration in older adults

Bioweapons risk could incorporate the consider arrival of an organic operator by aggressors that causes at least one wide range of infections. The utilization of compelling immunizations would prone to secure lives and breaking point malady spread in an organic weapons crisis. Authorized antibodies are at present accessible for a couple of dangers, for example, Bacillus anthracis and smallpox, and research is in progress to create and deliver immunizations for different dangers, for example, tularaemia, Ebola infection, and Marburg infection.


  • Track 10-1Anthrax and Smallpox
  • Track 10-2Ebola, Marburg, Lassa, and Machupo Virus
  • Track 10-3Nipah virus
  • Track 10-4Plague and Tularemia
  • Track 10-5Q fever, Ricin toxin, Typhus fever

Vaccination is the organization of antigenic material (an antibody) to animate a person's resistant framework to create versatile insusceptibility to a pathogen. Immunizations can forestall or improve irresistible malady. At the point when an adequately expansive level of a populace has been inoculated, group invulnerability comes about. The adequacy of immunization has been generally examined and confirmed. Inoculation is the best strategy for counteracting irresistible illnesses; across the board invulnerability because of immunization are to a great extent in charge of the overall destruction of smallpox and the end of maladies, for example, polio, measles, and lockjaw from a significant part of the world.


  • Track 11-1Age-specific Immune Response to Vaccination
  • Track 11-2Immunology / Animal Models
  • Track 11-3Novel Approaches in Design of Cellular and Molecular-Based Vaccines
  • Track 11-4Plant Based Vaccines & Combination Vaccines
  • Track 11-5Therapeutic Vaccination for Auto Immune Diseases
  • Track 11-6Vaccination in Pregnancy, New-borns and the Elderly populations
  • Track 11-7Vaccines against Vector-borne Diseases
  • Track 11-8Vaccines Related to Human Reproduction and Fertility Control

It is presently evident that numerous human tumor antigens can be perceived by the safe framework. These tumor antigens can be characterized into a few gatherings including malignancy testis, separation, tissue, over-communicated, and viral-related antigens. Enhanced comprehension of the science of the insusceptible reaction, especially of safe acknowledgment and initiation of T-cells, permit better plan of antibodies.


  • Track 12-1Antibody-targeted fusion proteins for Cancer Therapy
  • Track 12-2Autoimmunity & Biotechnology
  • Track 12-3Clinical Laboratory Immunology
  • Track 12-4Immune-mediated Neurological Syndromes
  • Track 12-5Immunological aspects of Endocrine diseases & Chronic diseases
  • Track 12-6Immunological aspects of infection
  • Track 12-7Monoclonal antibodies and Organ Cancers
  • Track 12-8Tumor Immunology and Immunotherapy

Various vaccinations require a couple of days or weeks to deliver comes about; you should anticipate any "holding period" a long time before you are to travel. Anybody intending to travel abroad may require vaccinations before takeoff. Albeit couples of inoculations are obligatory for global travel, some are prescribed for the explorer's insurance. A few antibodies must be given in 2–3 measurements half a month separated. In this way, a specialist ought to be counseled no less than 2–3 months previously takeoff.


  • Track 13-1Allergies and skin diseases in Traveller - Vaccinations
  • Track 13-2Challenges in implementing Immunization programs and Improvement strat
  • Track 13-3Health Considerations for Adventure Travel
  • Track 13-4Immunization in Immunocompromised patients
  • Track 13-5Travel immunizations and Safety issues

DNA vaccination is a system for ensuring a living being against infection by infusing it with hereditarily designed DNA to deliver an immunological reaction. As this DNA embedded into cells it is meant frame antigenic protein. As this protein is foreign to the cells, so resistant reaction raised against this protein. DNA antibodies are the third era immunizations and are comprised of a little, roundabout bit of bacterial DNA.


  • Track 14-1DNA vaccines against HIV/AIDS
  • Track 14-2Endogenous vaccinations
  • Track 14-3Exogenous vaccinations
  • Track 14-4MHC Classes
  • Track 14-5Plasmid DNA Vaccinations
  • Track 14-6Recombinant DNA Technology

HPV counter acting agent is basic since it guarantees against infections made by human papillomavirus (HPV) sullying. HPV is the most understood sexually-transmitted defilement in the US. HPV is regular to the point that all sexually powerful men and women will get no short of what one sort of HPV at some point or another in their lives. HPV inoculation offers tried and true security against HPV pollution and HPV related infection. There are a couple of sorts of hepatitis diseases including sorts A, B, C, D, E, and possibly G. Sorts A, B, and C are the most generally perceived. All hepatitis diseases can achieve extreme hepatitis.


  • Track 15-1Antiviral therapy-Immune system
  • Track 15-2Current advanced research on HPV
  • Track 15-3Hepatitis Viruses & Co-infection with HIV
  • Track 15-4HPV & Hepatitis Vaccines Current Updates
  • Track 15-5HPV Infection & Cancer
  • Track 15-6HPV Vaccines Safety, Prevention
  • Track 16-1Advances in DNA Vaccines, TLRS and Combination Adjuvants
  • Track 16-2Latest techniques and advancements in Vaccine delivery systems
  • Track 16-3Nano patch Technologies
  • Track 16-4Needle-free vaccine delivery
  • Track 16-5Routes & Medical devices for vaccines delivery
  • Track 16-6Transdermal Delivery of Vaccines
  • Track 16-7Vehicle, Mineral Salt & Bacteria Derived Adjuvants

Conveyance of an antibody in a program, for example, Expanded Program on Immunization is the final product of years of disclosure and advancement. Just a modest level of competitor antibodies advance to authorizing, making the expenses of immunization Research and Development amazingly high.

1. Pre-clinical advancement is inquire about completed in lab measures and on creatures.

2. Clinical improvement is the point at which the antibody is first tried in people. It covers four phases more than quite a long while, from starting clinical trials in people (stage I) directly through to presentation and past.


  • Track 17-1Current Challenges in Vaccine R & D
  • Track 17-2Current Focus in Virology Research
  • Track 17-3Regulatory and Economical Aspects in Virology
  • Track 17-4Viral Genomics and Proteomics

Immunization can be characterized as dynamic insusceptibility induced by antibody. It is invulnerability and immunologic memory much the same as regular contamination however without danger of malady. There are two fundamental sorts of antibodies: live constricted and inactivated. Live weakened immunizations are incited by changing an infection inducing infection or bacterium in a lab. Inactivated immunizations can be made out of either entire infections or microorganisms, or divisions of either.


  • Track 18-1Attenuated vaccine
  • Track 18-2Inactivated vaccine
  • Track 18-3Rotavirus
  • Track 18-4Rubella virus
  • Track 18-5Varicella zoster virus
  • Track 18-6Virus- Particles as vaccines, vectors and adjutants

Immunizer Genetic Engineering and Therapeutics meeting united a wide scope of members who were refreshed on the most recent advances in counter acting agent innovative work. Composed by IBC Life Sciences, the get-together is the yearly meeting of The Antibody Society, which fills in as the logical support. Preconference workshops on 3D demonstrating and outline of clonal ancestries were highlighted.


  • Track 19-1Antibodies and neuroscience
  • Track 19-2Antibodies as drugs: Immunological scaffolds as therapeutics
  • Track 19-3Antibody biology & engineering
  • Track 19-4Genetics and epigenetics of the immune system
  • Track 19-5Non antibody immunity

There is a unique CDC rules for the immunizations you require some time recently, amid, and after pregnancy. A few antibodies, for example, the measles, mumps, rubella (MMR) immunization, ought to be given a month or more before pregnancy. You ought to get a few antibodies, as Tdap (to ensure against whooping hack), amid pregnancy. Different immunizations, similar to this season's cold virus shot, can be given earlier or amid pregnancy, contingent upon whether pregnant.


  • Track 20-1Chiropractic vaccination care in women and pregnancy
  • Track 20-2Halting vaccination in pregnancy
  • Track 20-3HIV and other STD vaccines for pregnant women
  • Track 20-4HPB, HAV, HBV vaccination for neonates
  • Track 20-5Immunization during or before pregnancy / delivery
  • Track 20-6Influenza vaccination of pregnant women and protection of their infants
  • Track 20-7Whooping Cough vaccines in pregnant women

Patients with safe interceded incendiary ailments (IMID, for example, RA, IBD or psoriasis, are at augmented danger of contamination, in part in light of the malady itself, however for the most part in light of treatment with immunomodulatory or immunosuppressive medications. Regardless of their raised hazard for immunization preventable ailment, inoculation scope in IMID patients is shockingly low.


  • Track 21-1Central nervous system-targeted & Tissue-specific autoimmunity
  • Track 21-2Innate immunity and diabetes vaccines
  • Track 21-3Vaccination strategy in patients with IMID
  • Track 21-4Vaccine safety: impact on disease activity in IMID patients
  • Track 21-5Vaccines for autoimmune skin disorders & neuropathies
  • Track 21-6Vaccines for immunodeficiency diseases

Mosquito borne irresistible infections are among vital gathering of ailments around the world. Inoculation is accessible for some tropical mosquito-borne illnesses, particularly for Japanese encephalitis infection disease and yellow fever. There are additionally a few endeavors to grow new immunizations for the other mosquito-borne sicknesses, for example, jungle fever, dengue disease and West Nile infection contamination.


  • Track 22-1Helminthiasis
  • Track 22-2Progress and challenges
  • Track 22-3Protozoa
  • Track 22-4Viruses

A resistant reaction is an inactivated sort of microorganisms or tainting that is pervaded into the body to reenact a true blue illness. Since the embedded microorganisms are "dead," they don't accomplish a man to bend up wiped out. Or, on the other hand possibly, antibodies vivify a secured reaction by the body that will battle off that kind of confusion. It covers overwhelming infirmity targets and non-overpowering malady targets. To convey safe reaction interceded security is a confounding test


  • Track 23-1Bordetella vaccines
  • Track 23-2Chickenpox Vaccine & Measles Vaccines
  • Track 23-3Ebola Outbreak & Tuberculosis Vaccines
  • Track 23-4Emerging, Re-Emerging & Communicable Diseases
  • Track 23-5Meningococcal /Menactra Vaccines
  • Track 23-6Mucosal & Edible Vaccines
  • Track 23-7Pneumonia Vaccines
  • Track 23-8Rotavirus & Smallpox Vaccines

The revelation of vaccinations has provoked to the nearby demolition of a couple of basic diseases and has enormously influenced prosperity for a decently insignificant exertion. Regardless, most antibodies being utilized today were created by frameworks that were initiated more than 100 years earlier and don't address the greatest limit of the field. The introduction of innate building has controlled quick advances in counter acting agent development and is as of now provoking to the entry of new things in the business focus.


  • Track 24-1Personalized Medicine
  • Track 24-2Recent focus in Virology
  • Track 24-3Regulatory/societal/economic/programmatic and legislation subjects
  • Track 24-4Retroviral Diseases in Asia, Africa & Middle East
  • Track 24-5Vaccines Bioprocessing & Manufacturing
  • Track 24-6Vectors / adjuvants / drug delivery

Toxoid immunizations are produced using a poison (harm) that has been made safe however that inspires a resistant reaction against the poison. depend on the poison created by specific microbes (e.g. lockjaw or diphtheria). The poison attacks the circulatory system and is to a great extent in charge of the side effects of the ailment. The protein-based poison is rendered innocuous and utilized as the antigen in the immunization to evoke invulnerability.


  • Track 25-1Allergic reactions
  • Track 25-2Animal derived vaccines
  • Track 25-3Biotherapeutics
  • Track 25-4Development of Plant vaccines-Support
  • Track 25-5Hypersensitivity
  • Track 26-1Latest Innovations in vaccine
  • Track 26-2Live, attenuated, inactivated
  • Track 26-3New Vaccines